title: Subacute Cutaneous Lupus Erythematosus Induced by Mitotane.
authors.affiliation: Department of Dermatology, La Paz Hospital, Madrid, Spain.
authors.forename: Ander
authors.initials: A
authors.lastname: Mayor-Ibarguren
authors.affiliation: Department of Endocrinology, La Paz Hospital, Madrid, Spain.
authors.forename: María Concepción
authors.initials: MC
authors.lastname: Roldán-Puchalt
authors.affiliation: Department of Dermatology, La Paz Hospital, Madrid, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez-Fernández
authors.affiliation: Department of Dermatology, La Paz Hospital, Madrid, Spain.
authors.forename: Fátima
authors.initials: F
authors.lastname: Albízuri-Prado
authors.affiliation: Department of Endocrinology, La Paz Hospital, Madrid, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Álvarez-Escola
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy; D018268:Adrenocortical Carcinoma / Q000188:drug therapy; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*; D008875:Middle Aged; D008939:Mitotane / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane